What is precision oncology?
Precision oncology means selecting cancer treatment based on the molecular characteristics of the tumor rather than on its site of origin alone. Sequencing identifies the alterations driving growth, and where a therapy exists that targets that specific mechanism, treatment is matched to biology instead of to the organ.
The shift from organ to mechanism
Historically cancer was classified and treated by where it started: lung, breast, colon. Precision oncology adds a second axis. Two lung cancers with different driver mutations may warrant entirely different drugs, and a rare tumor with an NTRK fusion may respond to the same agent regardless of where it arose.
This is why tumor-agnostic approvals now exist. When the drug targets the mechanism, the organ of origin becomes less decisive.
Who benefits most
The approach matters most for advanced or metastatic disease, rare and unknown-primary tumors, cancers that have progressed on standard therapy, and any situation where a targeted agent or an immunotherapy biomarker is plausible.
- Advanced or metastatic solid tumors
- Rare cancers and cancers of unknown primary
- Progression after one or more standard lines of therapy
- Suspected hereditary contribution
- Any tumor where MSI, TMB, or PD-L1 could open an immunotherapy pathway
Honest limits
Not every tumor has an actionable alteration, and matching to a target does not guarantee response. Resistance develops. Some targeted drugs buy months rather than years. Precision oncology widens the option set and sharpens the reasoning; it does not promise an outcome, and any advisor who implies otherwise should be treated with caution.
Related questions
Is precision oncology the same as personalized medicine?
Broadly yes in cancer care, though precision oncology specifically refers to using molecular tumor data to guide treatment selection.
Does every cancer patient need genomic testing?
No. Testing is most informative in advanced, rare, or progressing disease. For some early-stage cancers with a clear standard of care, it changes nothing.
Does a targeted therapy always work if I have the target?
No. Co-occurring alterations, prior therapy, and resistance mechanisms all affect response, which is why interpretation matters as much as detection.
Reviewed 2026-08-13 by Kim Lockheimer, PhD, DFM.